YU46029B - Postopek za pripravo živega cepiva proti mumpsu - Google Patents

Postopek za pripravo živega cepiva proti mumpsu

Info

Publication number
YU46029B
YU46029B YU196986A YU196986A YU46029B YU 46029 B YU46029 B YU 46029B YU 196986 A YU196986 A YU 196986A YU 196986 A YU196986 A YU 196986A YU 46029 B YU46029 B YU 46029B
Authority
YU
Yugoslavia
Prior art keywords
live
diploid
procedure
mumps
attenuated
Prior art date
Application number
YU196986A
Other languages
English (en)
Other versions
YU196986A (en
Inventor
R. Glueck
R. Germanier
Original Assignee
Schweizerisches Serum- Und Impfinstitut Zur Erforschung Der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweizerisches Serum- Und Impfinstitut Zur Erforschung Der Infektionskrankheiten filed Critical Schweizerisches Serum- Und Impfinstitut Zur Erforschung Der Infektionskrankheiten
Publication of YU196986A publication Critical patent/YU196986A/xx
Publication of YU46029B publication Critical patent/YU46029B/sh
Priority to HRP-1969/86A priority Critical patent/HRP930279B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165—Mumps or measles virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0015—Combination vaccines based on measles-mumps-rubella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

POSTOPEK ZA PRIPRAVO ŽIVEGA CEPIVA PROTI MUMPSU, ki vsebuje žive, za razmnoževanje sposobne, pretežno s pasažami v kulturah diploidnega hamanega tkiva atenuirane viruse mumpsa, označen s tem, da viruse, dobljene iz urina pacientov z akutnim mumpsom, nadalje gojimo na diploidnem hamanem tkivu, atenuiramo s ponovljenimi pasažami v takem tkviu in v embrioniranih kokošjih jajcih, nadalje atenuiramo z nadaljnjimi pasažami v diploidnem humanem tkivu in s tem adaptiramo na človeško tkivo, izoliramo, nato kultiviramo i predelamo v živo cepivo. (prior.26.nov.1985). Priprava vsebuje še 1 patentni zahtevek.
YU196986A 1985-11-26 1986-11-18 Postopek za pripravo živega cepiva proti mumpsu YU46029B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-1969/86A HRP930279B1 (en) 1985-11-26 1993-03-08 Process for preparing living vaccine against mumps

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH506285 1985-11-26
CH13386 1986-01-15

Publications (2)

Publication Number Publication Date
YU196986A YU196986A (en) 1988-10-31
YU46029B true YU46029B (sh) 1992-12-21

Family

ID=25683616

Family Applications (1)

Application Number Title Priority Date Filing Date
YU196986A YU46029B (sh) 1985-11-26 1986-11-18 Postopek za pripravo živega cepiva proti mumpsu

Country Status (8)

Country Link
US (1) US5006335A (sh)
EP (1) EP0223915B1 (sh)
AU (1) AU586299B2 (sh)
CA (1) CA1286226C (sh)
DE (1) DE3676960D1 (sh)
ES (1) ES2000034A6 (sh)
PT (1) PT83544B (sh)
YU (1) YU46029B (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US6022726A (en) * 1992-02-03 2000-02-08 Palese; Peter Genetically engineered attenuated viruses
US6316243B1 (en) 1992-04-14 2001-11-13 Peter Palese Genetically engineered attenuated double-stranded RNA viruses
EP0736089A4 (en) * 1993-12-21 1999-08-11 Merck & Co Inc THERMOSTABLE VARICELLA ZOSTER VIRUS
US6872547B1 (en) 2000-10-11 2005-03-29 Washington University Functional balanced-lethal host-vector systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514374A (en) * 1968-04-02 1970-05-26 Merck & Co Inc Method of purification of myxovirus vaccine
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
JPS528379B1 (sh) * 1971-04-30 1977-03-09
US3961046A (en) * 1974-12-02 1976-06-01 American Cyanamid Company Mumps vaccine and preparation thereof
JPS55147227A (en) * 1979-05-04 1980-11-17 Handai Biseibutsubiyou Kenkyukai Preparrtion of attenuated live mumps vaccine
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines

Also Published As

Publication number Publication date
CA1286226C (en) 1991-07-16
YU196986A (en) 1988-10-31
AU586299B2 (en) 1989-07-06
PT83544A (fr) 1986-11-01
EP0223915A2 (de) 1987-06-03
EP0223915A3 (en) 1989-05-17
ES2000034A6 (es) 1987-10-01
AU6579486A (en) 1987-05-28
DE3676960D1 (de) 1991-02-21
US5006335A (en) 1991-04-09
PT83544B (pt) 1988-11-30
EP0223915B1 (de) 1991-01-16

Similar Documents

Publication Publication Date Title
Nakahara et al. Bone and cartilage formation in diffusion chambers by subcultured cells derived from the periosteum
Koch The etiology of tuberculosis
Graf et al. Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vivo studies with avian erythroblastosis virus
Carrel Tissue culture and cell physiology
ATE7201T1 (de) Verfahren zur herstellung eines bakteriellen praeparates zur verhuetung von darmbeschwerden beim gefluegel.
FI930206A (fi) Adoptiv immunoterapi med interleukin-7
DE69022290D1 (de) Lebende Impfstoffe.
FI882707A (fi) Foerfarande och preparat foer hoejning av proteinhalten i mjoelk.
Zetter et al. Thrombin potentiates the mitogenic response of cultured fibroblasts to serum and other growth promoting agents
Kato et al. The inductive transformation of the chorionic epithelium into skin derivatives
YU46029B (sh) Postopek za pripravo živega cepiva proti mumpsu
Dalldorf Viruses and human cancer
FR2455628A1 (fr) Procede de preparation d'un virus vaccinal vivant attenue contre les oreillons
NL7800708A (nl) Nieuw rabies vaccin.
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
C ANDREW BASSETT et al. Characteristics and potentials of long term cultures of human skin
Lefkowitz et al. Cultivation of rat molar tooth germs in Carrel flasks. I
ATE361975T1 (de) Tiermodell für hepatitis-virus infektion
HUP0101081A2 (hu) Tápközeg és eljárás vírustenyésztésre és szaporításra
Marks et al. Regenerating tissues from the cockroach Leucophaea maderae: Effects of endocrine glands in vitro
EP0236988A3 (en) Process for stimulating the growth and the health of crops
MX9602256A (es) Vacuna contra la enfermedad de marek.
SE9403636D0 (sv) Vaccine preparation
Hore Study of the Structure and Behaviour of Chromosomes of the Different Varieties of Apium graveolens (Celery)
Benedek et al. Effect of vaccinia on cells grown in tissue culture